Last reviewed: June 8, 2026
Last updated: June 8, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Many patients starting semaglutide injections ask when they will notice the medication working. Clinical data shows that appetite suppression can begin within 3–5 days of the first dose, but individual timelines vary based on genetics, metabolism, and starting dosage. Understanding this timeline helps set realistic expectations during your first month of treatment.
When Does Semaglutide Appetite Suppression Start?
Semaglutide works by activating GLP-1 receptors in your brain and digestive system, signaling fullness and reducing hunger hormones. Most patients report noticing reduced appetite within 3–7 days of their first injection, though some feel changes even sooner. The medication's onset depends on your body's receptor sensitivity, which is partly determined by genetic variants like GLP1R rs6923761.
Your initial dose size affects how quickly you sense the effect. Lower starting doses may take slightly longer to produce noticeable appetite changes than higher doses, but PlexusDx begins all patients at medically appropriate levels. Consistent weekly injections allow the medication to accumulate in your system, creating a stronger and more stable appetite-suppressing effect by week 2–3.
Weight Loss Timeline: Weeks 1–4 on Semaglutide Injection
During your first week, most patients experience reduced cravings and smaller portion sizes at meals. Some initial weight loss in week 1 may reflect water loss and decreased food volume rather than fat loss. By week 2–3, as your body adapts to lower calorie intake, you may see more measurable weight changes on the scale.
Clinical trial data shows that patients typically lose 2–4 pounds in the first month of semaglutide therapy, with faster results appearing by weeks 3–4. This early momentum builds confidence and reinforces behavior changes. PlexusDx Semaglutide Injection (starting at $149/month) is dosed to support steady progress without requiring price increases as your treatment advances.
Factors That Influence Your Personal Response Timeline
Your genetics play a significant role in how quickly semaglutide produces results. Variants in the FTO gene (rs9939609) and MC4R gene (rs17782313) affect baseline hunger signaling and metabolic rate, influencing both onset and magnitude of appetite suppression. PlexusDx offers the Precision Peptide Genetic Test ($99 add-on) to map your peptide-pathway genetics across 49 peptides and 150+ insights, helping predict your personal response timeline.
Other factors affecting timeline include your starting weight, baseline metabolic rate, diet quality, physical activity level, and whether you take other medications. Patients with higher starting weights often see faster initial weight loss due to greater calorie deficit potential. Consistent meal timing, adequate hydration, and regular movement amplify semaglutide's effectiveness and accelerate results.
What to Track During Your First Month of Treatment
Keep a simple log of appetite changes, portion sizes, and energy levels rather than weighing yourself daily. Note when you first notice reduced cravings, how long you feel full after meals, and whether certain foods become less appealing. This personal data helps your PlexusDx provider assess whether your dose is appropriate or needs adjustment.
Weigh yourself once per week at the same time and under similar conditions to see realistic trends. Most patients see measurable weight loss by day 14–21, but some require the full month to register changes on the scale. If you experience side effects like mild nausea or changes in appetite at unexpected times, document these for your provider—they inform whether a dose adjustment would improve your experience.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
How many days after my first semaglutide injection will I notice reduced appetite?
Most patients report reduced hunger within 3–7 days of their first injection. Some feel changes as early as day 2, while others notice effects more gradually by day 10. Your genetics, starting dose, and individual metabolism determine your exact timeline. PlexusDx Semaglutide Injection patients can contact their provider if appetite changes don't appear within the first two weeks.
Will I lose weight in week one of semaglutide therapy?
Some initial weight loss may occur in week one, primarily from reduced food intake and water loss rather than fat loss. Meaningful fat loss typically appears by week 2–4 as your body adapts to lower calorie intake consistently. Clinical trials show average weight loss of 2–4 pounds in month one, with faster results appearing by weeks 3–4.
Does my dose level affect how quickly semaglutide starts working?
Yes, higher starting doses typically produce noticeable appetite suppression faster than lower doses. However, PlexusDx begins all patients at medically appropriate starting levels based on medical history and safety guidelines. Your dose may need to go up over time for continued progress—but your price stays flat at $149/month, so you never pay more as your treatment advances.
What if I don't feel semaglutide working after two weeks?
Some patients require the full first month before registering significant appetite changes or scale weight loss. Genetics influence response speed, so variation is normal. If you feel no appetite change by day 21, contact PlexusDx to discuss whether a dose adjustment or medication switch might suit your body better. The Precision Peptide Genetic Test can reveal whether your GLP1R and GIPR genetic pathways suggest optimal semaglutide response.
Does the PlexusDx Precision Peptide Genetic Test predict my semaglutide timeline?
Yes. The test ($99 add-on after your first month) analyzes key variants including GLP1R rs6923761, GIPR rs1800437, and FTO rs9939609, which influence appetite suppression speed and weight loss potential. Patients with certain GLP1R variants often experience faster onset and stronger appetite suppression, helping explain individual timeline differences across the 150+ peptide-pathway insights PlexusDx provides.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Does Ozempic Help You Stop Drinking?
When to Start GLP-1: Your Guide to Effective Weight Loss